Inventor · disambiguated record
Srikant Viswanadha
Also filed as: VISWANADHA SRIKANT
39 granted patents·14 pending applications·96 citations·filing 2010–2023
97Inventor score
Files withRHIZEN PHARMACEUTICALS SA36RHIZEN PHARMACEUTICALS AG6MUTHUPPALANIAPPAN MEYYAPPAN5INCOZEN THERAPEUTICS PVT LTD4NAGARATHNAM DHANAPALAN2
Top patents by PatentIndex Score
53 records- 0193US8921364B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2012·Granted Dec 30, 2014·7 cites·23 claims
- 0293US8642607B24H-chromen-4-one compounds as modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Feb 4, 2014·17 cites·23 claims
- 0392US8912331B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2013·Granted Dec 16, 2014·17 cites·28 claims
- 0492US8377970B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2010·Granted Feb 19, 2013·7 cites·28 claims
- 0589US9018375B2Substituted chromenes as kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Apr 28, 2015·8 cites·5 claims
- 0686US8481739B23,5-Disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H[1,2,3]triazolo [4,5-b] Pyridine Compounds as Modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Jul 9, 2013·7 cites·47 claims
- 0785US9421209B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Aug 23, 2016·3 cites·13 claims
- 0884US10087182B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2017·Granted Oct 2, 2018·3 cites·9 claims
- 0983US9815831B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Nov 14, 2017·5 cites·32 claims
- 1083US9737521B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2013·Granted Aug 22, 2017·4 cites·21 claims
- 1181US10220035B2Compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Mar 5, 2019·2 cites·12 claims
- 1281US2024360095A1Novel kinase modulatorsRHIZEN PHARMACEUTICALS AG·Filed 2023·Application pending·0 cites
- 1380US9783533B2Glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 10, 2017·4 cites·13 claims
- 1480US9758514B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·47 claims
- 1580US8993612B2Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2010·Granted Mar 31, 2015·6 cites·14 claims
- 1678US11858907B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jan 2, 2024·0 cites·18 claims
- 1775US9775841B2Compounds as modulators of protein kinasesNAGARATHNAM DHANAPALAN·Filed 2012·Granted Oct 3, 2017·2 cites·6 claims
- 1874US2021401840A1Novel compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 1971US9777018B2Compounds as modulators of GPR-119RHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Oct 3, 2017·1 cites·36 claims
- 2070US11466006B2Dual selective PI3 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Granted Oct 11, 2022·0 cites·10 claims
- 2170US11020399B2Intermediates useful in the synthesis of compounds as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 1, 2021·0 cites·2 claims
- 2270US9758474B2Immunomodulator and anti-inflammatory compoundsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Sep 12, 2017·1 cites·8 claims
- 2369US10668051B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jun 2, 2020·0 cites·20 claims
- 2469US10246450B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Apr 2, 2019·0 cites·19 claims
- 2569US8686048B2Immunomodulator and anti-inflammatory compoundsMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2011·Granted Apr 1, 2014·1 cites·7 claims
- 2668US2021371416A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of c-met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2021·Application pending·0 cites
- 2767US11065236B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2019·Granted Jul 20, 2021·0 cites·13 claims
- 2867US9944631B2Modulators of calcium release-activated calcium channelRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Apr 17, 2018·0 cites·15 claims
- 2964US10590129B23,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2018·Granted Mar 17, 2020·0 cites·9 claims
- 3064US10413532B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2018·Granted Sep 17, 2019·0 cites·14 claims
- 3164US2015133449A1Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinasesINCOZEN THERAPEUTICS PVT LTD·Filed 2014·Application pending·0 cites
- 3264US2021032236A1Novel glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 3363US10538501B2Kinase modulatorsRHIZEN PHARMACEUTICALS SA·Filed 2016·Granted Jan 21, 2020·0 cites·22 claims
- 3463US10058539B2Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitorRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Aug 28, 2018·0 cites·33 claims
- 3562US9790224B2Dual selective PI3 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2014·Granted Oct 17, 2017·0 cites·32 claims
- 3661US10851107B2Dual selective P13 delta and gamma kinase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Dec 1, 2020·0 cites·23 claims
- 3761US10611759B2Glutaminase inhibitorsRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Apr 7, 2020·0 cites·25 claims
- 3861US10322130B2Substituted chromenones as modulators of protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jun 18, 2019·0 cites·35 claims
- 3958US10442783B22,3-disubstituted chromen-4-one compounds as modulators of protein kinasesMUTHUPPALANIAPPAN MEYYAPPAN·Filed 2010·Granted Oct 15, 2019·0 cites·33 claims
- 4058US2021030757A1Method of treatment and compositions comprising a dual p13k delta-gamma kinase inhibitor and a corticosteroidRHIZEN PHARMACEUTICALS SA·Filed 2020·Application pending·0 cites
- 4157US12428422B2Purine derivatives as SIK-3 inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2021·Granted Sep 30, 2025·0 cites·6 claims
- 4255US11066402B23,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinasesRHIZEN PHARMACEUTICALS SA·Filed 2017·Granted Jul 20, 2021·0 cites·19 claims
- 4354US2019248791A1Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancerRHIZEN PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4454US2017342089A1Novel compounds as modulators of gpr-119RHIZEN PHARMACEUTICALS SA·Filed 2017·Application pending·0 cites
- 4554US2024199582A1Inhibitors of poly(adp-ribose) polymeraseRHIZEN PHARMACEUTICALS AG·Filed 2022·Application pending·0 cites
- 4651US9181214B2Bicyclic compounds as modulators of GPR-119NAGARATHNAM DHANAPALAN·Filed 2012·Granted Nov 10, 2015·0 cites·33 claims
- 4751US2020281918A1Calcium release-activated calcium channel modulators for treating hematological and solid cancersRHIZEN PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4851US2020237743A1Crac channel modulators for treating esophageal cancerRHIZEN PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 4948US10786504B2Method of treatment and compositions comprising a dual PI3K delta-gamma kinase inhibitor and a corticosteroidRHIZEN PHARMACEUTICALS SA·Filed 2015·Granted Sep 29, 2020·0 cites·31 claims
- 5048US2023234938A1Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2021·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Srikant Viswanadha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →